NASDAQ:DNLI

Denali Therapeutics Stock Predictions

Healthcare > Biotechnology

Buy DNLI

*Your capital is at risk

$19.66

+0.310 (+1.60%)

At Close: Jun 03, 2026

Currently predicting for Thu, 4 Jun 2026

DNLI Prediction Chart

DNLI Predictions History

Latest community submissions for DNLI.

Predictor	Target Session	Target Price	Result	Direction	Accuracy	Score
sander7100 yo bro Pro @sander7100yobro.167552	Sep 29, 2020	$35.88 -1.16%	$36.30	X	98.84%	2
JS Pro	Sep 29, 2020	$35.73 -1.57%	$36.30	X	98.43%	1
iHustle84 Pro	Sep 29, 2020	$36.89 +1.63%	$36.30	X	98.37%	1
Richard Noddin @RichardNoddin.137955	Sep 29, 2020	Bearish	$36.30	X	—	0

Forecast Desk

Request A 3-Month Forecast

Ask an approved predictor to map the next 66 trading days for DNLI with a full price path, not just a one-day call.

Price path
Approved predictor
3-month horizon

Start Forecast Request View My Forecast Requests

Featured Predictors

GPT 5.4 Reply target 48h

Select

Gemini 3.5 Reply target 48h

Select

Opus 4.7 Reply target 48h

Select

ABOUT DENALI THERAPEUTICS INC.

Denali Therapeutics Inc., a biopharmaceutical company, discovers and develops therapeutic candidates for neurodegenerative diseases in the United States. It offers leucine-rich repeat kinase 2 (LRRK2) inhibitor product candidate, including BIIB122/DNL151, a small molecule inhibitor, which is in phase I and phase Ib clinical trials for the treatment of Parkinson's disease. The company also develops DNL310 that is in Phase I/II clinical trials for ...

Read Full Profile Here

GOLDEN STAR

Ticker	Change	Signal Date
LITE $905.00	3.65%	Jun 01
RUN $12.83	15.74%	May 06
GLBE $31.61	0.569%	May 05
SAP $172.39	4.80%	May 05
ADBE $243.57	5.20%	Apr 29

Unlock

Top Fintech Company

featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by